• Ceramide-Driven Autophagy Fuels Fish Nodavirus Replication

  2026-07-15

  This study uses global lipidomics to reveal that ceramide accumulation is a critical pro-viral mechanism during red-spotted grouper nervous necrosis virus (RGNNV) infection. By delineating the metabolic and molecular interplay between ceramide synthesis and autophagy, the work identifies new intervention points for antiviral strategies in aquaculture.

• CD163+ Macrophages Drive Granulosa Cell Apoptosis in PCOS

  2026-07-15

  This study demonstrates that increased activation of CD163+ macrophages in the ovary promotes granulosa cell apoptosis and inflammatory signaling in polycystic ovary syndrome (PCOS). These mechanistic insights clarify the immuno-inflammatory contribution to impaired follicular development, highlighting CD163 as a potential target in PCOS research.

• NADPH Oxidase-Derived ROS Drive Arterial Contraction via L-t

  2026-07-14

  This study elucidates how NADPH oxidase-generated ROS promote arterial contraction in early postnatal rats by activating L-type voltage-gated Ca2+ channels, rather than through Rho-kinase, PKC, or Src-kinase pathways. These findings clarify developmental nuances in vascular regulation and inform precise experimental design for vascular signaling research.

• Angiotensin 1/2 (1-6): Molecular Insights for Precision Vasc

  2026-07-14

  Explore the advanced molecular mechanisms and translational research opportunities enabled by Angiotensin 1/2 (1-6). This in-depth analysis reveals unique assay guidance and highlights new frontiers in cardiovascular and renal studies.

• Naloxone Hydrochloride in Research: Protocols & Innovations

  2026-07-13

  Naloxone hydrochloride is redefining opioid receptor antagonist research, offering high-purity, reproducible performance across neural, behavioral, and immune assays. This article delivers actionable protocols, troubleshooting guidance, and comparative insights, empowering researchers to unlock new frontiers in opioid signaling and neural stem cell biology.

• Sulforaphane for Oxidative Stress and Cancer Chemoprevention

  2026-07-13

  Sulforaphane, a potent isothiocyanate, enables precise modeling of oxidative stress and inflammasome-driven inflammation across cancer and IBD research. This guide details applied workflows, troubleshooting, and protocol optimization using high-purity APExBIO sulforaphane.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit:

  2026-07-12

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit (SKU K4136) is designed to resolve proteins and peptides in the 1–10 kDa range, addressing the limitations of standard Tris-glycine SDS-PAGE for small molecule separation. This kit is intended strictly for research applications and is not suitable for diagnostic or clinical use.

• Ciprofloxacin (SKU A8399): Reliable Workflows for Antimicrob

  2026-07-10

  This article delivers scenario-driven, evidence-based guidance for using Ciprofloxacin (SKU A8399) in contemporary antimicrobial resistance research. By translating recent findings and practical lab challenges into actionable recommendations, it demonstrates how APExBIO’s high-purity Ciprofloxacin supports reproducible, sensitive, and efficient experimental outcomes for biomedical researchers and technicians.

• Cefiderocol Activity Against Resistant Enterobacterales in E

  2026-07-09

  The referenced study rigorously evaluates the in vitro efficacy of cefiderocol against a broad collection of European Enterobacterales, including strains resistant to meropenem and advanced β-lactam/β-lactamase inhibitor combinations. The findings reveal cefiderocol’s superior or comparable activity, highlighting its potential as a single-agent option for tackling multidrug-resistant Gram-negative infections in clinical and research settings.

• Lopinavir (ABT-378): Potent HIV Protease Inhibitor Benchmark

  2026-07-09

  Lopinavir (ABT-378) is a highly potent HIV protease inhibitor with picomolar inhibition constants and robust efficacy against resistance mutations. It demonstrates consistent antiviral activity in serum and enables advanced HIV drug resistance studies. This article details its mechanism, evidence, and integration into HIV infection research workflows.

• Allosteric PDK4 Inhibitors for Metabolic Disease Interventio

  2026-07-08

  This article examines the discovery and characterization of novel allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, focusing on compound 8c and its metabolic, immunological, and oncological implications. The findings provide a new chemical scaffold for targeting metabolic disease, allergic responses, and cancer, with detailed insights into mechanisms and translational relevance.

• Staurosporine and the Paradox of Apoptosis in Metastatic Can

  2026-07-08

  Explore the dual role of Staurosporine as a broad-spectrum serine/threonine protein kinase inhibitor and apoptosis inducer in cancer cell lines. This in-depth analysis connects kinase inhibition, recent metastasis research, and practical protocols, providing new insight for advanced cancer research applications.

• Tapuy Lees Attenuate Neurodegeneration in C. elegans Disease

  2026-07-07

  The study by Remucal et al. demonstrates that Tapuy lees, a by-product of traditional Filipino rice wine, significantly reduce amyloid-β toxicity and dopaminergic neuronal loss in C. elegans models of Alzheimer's and Parkinson's diseases. These findings highlight the neuroprotective and antioxidant potential of indigenous food-derived extracts in preclinical neurodegeneration research.

• 25-Hydroxycholesterol Drives AMPKα Activation in Tumor Macro

  2026-07-07

  Xiao et al. (2024) reveal how lysosomal 25-hydroxycholesterol modulates macrophage immunosuppression by activating AMPKα through a GPR155–mTORC1 pathway, ultimately enhancing STAT6-dependent gene expression. This mechanistic insight highlights metabolic reprogramming as a regulatory axis in tumor immunity and suggests new strategies for targeting tumor-associated macrophages.

• FAISL lncRNA Prevents FAK Proteolysis to Drive TNBC Metastas

  2026-07-06

  The reference study identifies the long noncoding RNA FAISL as a direct stabilizer of focal adhesion kinase (FAK) in triple negative breast cancer (TNBC), blocking Calpain 2-mediated proteolysis and promoting tumor progression. These findings illuminate a previously unrecognized mechanism of FAK regulation in cancer and suggest new therapeutic targets for aggressive breast tumors.

15588 records 1/1040 page Next 12345 下5页 Last page